Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia
| dc.contributor.author | Dunaiski, Cara M. | |
| dc.contributor.author | Kock, Marleen M. | |
| dc.contributor.author | Jung, Hyunsul | |
| dc.contributor.author | Peters, Remco P. H. | |
| dc.date.accessioned | 2023-09-18T10:02:56Z | |
| dc.date.available | 2023-09-18T10:02:56Z | |
| dc.date.issued | 2022-08-15 | |
| dc.date.updated | 2022-08-21T03:10:30Z | |
| dc.description.abstract | Abstract Background Vaginal discharge syndrome (VDS) is a common condition. Clinical management targets sexually transmitted infections (STIs) and bacterial vaginosis (BV); there is limited focus on Candida infection as cause of VDS. Lack of Candida treatment coverage and, if present, antifungal resistance may result in VDS treatment failure. This study aimed to determine the prevalence of Candida infection, antifungal resistance, and coinfections in Namibian women with VDS. Methods A cross-sectional study was performed using 253 vaginal swabs from women with VDS in Namibia. Demographic data was collected, and phenotypic and molecular detection of Candida species was performed followed by fluconazole susceptibility testing of Candida isolates. BV was diagnosed using Nugent score microscopy; molecular detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis was performed. Results Candida species was detected in 110/253 women (43%). Ninety women (36%) had Candida albicans and 24 (9.5%) had non-albicans Candida species. The non-albicans species detected were 19 (17%) Candida glabrata, 4.0 (3.5%) Candida krusei, and 1.0 (0.9%) Candida parapsilosis. Candida albicans were more frequently isolated in younger (p = 0.004) and pregnant women (p = 0.04) compared to non-albicans Candida species. Almost all (98%) Candida albicans isolates were susceptible to fluconazole while all non-albicans Candida species were fluconazole resistant. STIs were diagnosed in 92 women (36%): 30 (12%) with C. trachomatis, 11 (4.3%) N. gonorrhoeae, and 70 (28%) T. vaginalis; 98 (39%) women had BV. Candida infection alone was diagnosed in 30 women (12%), combined with STIs in 42 women (17%) and was concurrent with BV in 38 women (15%). Candida infection was more often detected in swabs from women without C. trachomatis detected (6.4% vs. 16%; OR 0.30; 95% CI 0.10–0.77, p = 0.006). Conclusions The high prevalence of Candida infection, especially those due to non-albicans Candida species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes. Access to microbiological testing for Candida species in the context of syndromic management is warranted. | |
| dc.identifier.apacitation | Dunaiski, Cara M., Kock, Marleen M., Jung, H., & Peters, Remco P. H. (2022). Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. http://hdl.handle.net/11427/38719 | en_ZA |
| dc.identifier.chicagocitation | Dunaiski, Cara M., Marleen M. Kock, Hyunsul Jung, and Remco P. H. Peters "Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia." (2022) http://hdl.handle.net/11427/38719 | en_ZA |
| dc.identifier.citation | Antimicrobial Resistance & Infection Control. 2022 Aug 15;11(1):104 | |
| dc.identifier.ris | TY - Journal Article AU - Dunaiski, Cara M. AU - Kock, Marleen M. AU - Jung, Hyunsul AU - Peters, Remco P. H. AB - Abstract Background Vaginal discharge syndrome (VDS) is a common condition. Clinical management targets sexually transmitted infections (STIs) and bacterial vaginosis (BV); there is limited focus on Candida infection as cause of VDS. Lack of Candida treatment coverage and, if present, antifungal resistance may result in VDS treatment failure. This study aimed to determine the prevalence of Candida infection, antifungal resistance, and coinfections in Namibian women with VDS. Methods A cross-sectional study was performed using 253 vaginal swabs from women with VDS in Namibia. Demographic data was collected, and phenotypic and molecular detection of Candida species was performed followed by fluconazole susceptibility testing of Candida isolates. BV was diagnosed using Nugent score microscopy; molecular detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis was performed. Results Candida species was detected in 110/253 women (43%). Ninety women (36%) had Candida albicans and 24 (9.5%) had non-albicans Candida species. The non-albicans species detected were 19 (17%) Candida glabrata, 4.0 (3.5%) Candida krusei, and 1.0 (0.9%) Candida parapsilosis. Candida albicans were more frequently isolated in younger (p = 0.004) and pregnant women (p = 0.04) compared to non-albicans Candida species. Almost all (98%) Candida albicans isolates were susceptible to fluconazole while all non-albicans Candida species were fluconazole resistant. STIs were diagnosed in 92 women (36%): 30 (12%) with C. trachomatis, 11 (4.3%) N. gonorrhoeae, and 70 (28%) T. vaginalis; 98 (39%) women had BV. Candida infection alone was diagnosed in 30 women (12%), combined with STIs in 42 women (17%) and was concurrent with BV in 38 women (15%). Candida infection was more often detected in swabs from women without C. trachomatis detected (6.4% vs. 16%; OR 0.30; 95% CI 0.10–0.77, p = 0.006). Conclusions The high prevalence of Candida infection, especially those due to non-albicans Candida species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes. Access to microbiological testing for Candida species in the context of syndromic management is warranted. DA - 2022-08-15 DB - OpenUCT DP - University of Cape Town KW - Candida albicans KW - Non-albicans Candida species KW - Vaginal discharge syndrome KW - Antifungal susceptibility testing KW - Sexually transmitted infections KW - Namibia KW - Sub-Saharan Africa LK - https://open.uct.ac.za PY - 2022 T1 - Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia TI - Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia UR - http://hdl.handle.net/11427/38719 ER - | en_ZA |
| dc.identifier.uri | https://doi.org/10.1186/s13756-022-01143-6 | |
| dc.identifier.uri | http://hdl.handle.net/11427/38719 | |
| dc.identifier.vancouvercitation | Dunaiski Cara M, Kock Marleen M, Jung H, Peters Remco P H. Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. 2022; http://hdl.handle.net/11427/38719. | en_ZA |
| dc.language.rfc3066 | en | |
| dc.publisher | BioMed Central | |
| dc.rights.holder | The Author(s) | |
| dc.subject | Candida albicans | |
| dc.subject | Non-albicans Candida species | |
| dc.subject | Vaginal discharge syndrome | |
| dc.subject | Antifungal susceptibility testing | |
| dc.subject | Sexually transmitted infections | |
| dc.subject | Namibia | |
| dc.subject | Sub-Saharan Africa | |
| dc.title | Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia | |
| dc.type | Journal Article |